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Abstract
Background: Duchenne muscular dystrophy (DMD), caused by mutations in the dystrophin gene, is associated with severe
cardiac complications including cardiomyopathy and cardiac arrhythmias. Recent research suggests that impaired voltage-
gated ion channels in dystrophic cardiomyocytes accompany cardiac pathology. It is, however, unknown if the ion channel
defects are primary effects of dystrophic gene mutations, or secondary effects of the developing cardiac pathology.
Methodology/Principal Findings: To address this question, we first investigated sodium channel impairments in
cardiomyocytes derived from dystrophic neonatal mice prior to cardiomyopahty development, by using the whole cell
patch clamp technique. Besides the most common model for DMD, the dystrophin-deficient mdx mouse, we also used mice
additionally carrying an utrophin mutation. In neonatal cardiomyocytes, dystrophin-deficiency generated a 25% reduction
in sodium current density. In addition, extra utrophin-deficiency significantly altered sodium channel gating parameters.
Moreover, also calcium channel inactivation was considerably reduced in dystrophic neonatal cardiomyocytes, suggesting
that ion channel abnormalities are universal primary effects of dystrophic gene mutations. To assess developmental
changes, we also studied sodium channel impairments in cardiomyocytes derived from dystrophic adult mice, and
compared them with the respective abnormalities in dystrophic neonatal cells. Here, we found a much stronger sodium
current reduction in adult cardiomyocytes. The described sodium channel impairments slowed the upstroke of the action
potential in adult cardiomyocytes, and only in dystrophic adult mice, the QRS interval of the electrocardiogram was
prolonged.
Conclusions/Significance: Ion channel impairments precede pathology development in the dystrophic heart, and may thus
be considered potential cardiomyopathy triggers.
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Introduction
Duchenne muscular dystrophy (DMD) is the most common and
devastating form among the human muscular dystrophies. The
disease is characterised by progressive muscle weakness with cycles
of muscle necrosis and regeneration. The gene defect for DMD
was mapped to an X chromosome gene that encodes the
intracellular protein dystrophin. This protein seems to act as a
linker between the cytoskeleton and the extracellular matrix
through its interaction with proteins of the dystrophin-associated
protein complex (DAPC) [1]. Besides the relatively well described
skeletal muscle degenerative processes, DMD and some other
muscular dystrophy types are also associated with cardiac
complications, including cardiomyopathy and cardiac arrhythmias
[2,3]. These contribute significantly to the morbidity and mortality
observed [2,4], and, considering the increased life span of
dystrophy patients nowadays, have become a crucial issue [4,5].
The current understanding of the mechanisms generating cardiac
complications, however, is limited.
In recent years it has become apparent that ion channels are
part of large multi-protein complexes [6]. Disruption of any
protein member of such a particular ‘‘ion channel complex’’ has
the potential to affect the function and localisation of the
associated channels, and consequently, may alter cellular excit-
ability. Recent research has exposed that also protein members of
the DAPC interact with voltage-gated ion channels. For example,
the main cardiac sodium channel isoform Nav1.5 interacts with
dystrophin [7] and syntrophins [7,8], and these interactions
modulate the channel. Accordingly, disruption of the DAPC in
dystrophin-deficient cardiomyocytes from the mdx mouse (most
commonly used mouse model for human DMD with a mutation in
the dystrophin gene [9]) induces reduced Nav1.5 protein levels and
sodium current densities [5,7,10]. Importantly, decreased sodium
current may contribute to the impairment in cardiac electrical
conduction observed in DMD patients (e.g. [11,12]).
Lately, transgenic mice with reduced expression of Nav1.5
channels in the heart were shown to develop a dilated
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the reduction in sodium current was, the faster was also the onset
and progression of the cardiomyopathy. These findings, together
with reports associating mutations in the SCN5A gene (coding for
the cardiac Nav1.5 channel) with cardiomyopathy (e.g. [14,15]),
strongly suggest that aberrant Nav1.5 channel expression and
function should be considered as potential underlying mechanisms
for cardiomyopathy. Since cardiomyopathy development is also an
important feature of the pathology observed in DMD patients [2,3],
as well as in DMD mouse models (e.g. [16–18]), reduced Nav1.5
currents and/or impaired Nav1.5 channel gating in dystrophic
cardiomyocytes [7,10] may be causally involved in the formation of
dystrophic cardiomyopathy. If so, sodium channel impairments
should precede cardiomyopathy development in the dystrophic
heart, which has not been demonstrated as yet.
To test the hypothesis that ion channel abnormalities occur prior to
cardiac pathology, in this study, we investigated the functional
properties of both sodium and calcium channels in cardiomyocytes
derived from the ventricles of dystrophic neonatal mouse hearts.
Besides the dystrophin-deficient mdx mouse, we also used mice
additionally carrying a mutation in the utrophin gene [16,19]. The
latter mouse model (mdx-utr) more closely resembles the general
pathology observed in DMD patients, and develops a more severe
cardiomyopathy with an earlier onset compared to mdx (e.g.
[16,20]). Because both young adult mdx mice (e.g. [16,18,21–23]),
as well as mdx-utr double mutant mice of less than seven weeks of
age [16] lack any signs of pathological cardiac morphology or
impaired heart function, ion channel defects observed in dystrophic
neonatal cardiomyocytes can be considered primary effects of
dystrophic gene mutations preceding cardiomyopathy develop-
ment. Here we report that ion channel abnormalities are already
present in cardiomyocytes of the dystrophic neonatal heart.
Results
Sodium current properties in normal and dystrophic
neonatal cardiomyocytes
Figure 1 shows typical original traces of sodium currents (A)
elicited by various depolarizing voltage steps of a wt, mdx, and
mdx-utr cardiomyocyte. In addition, a summary of the current-
voltage relationships (B), derived from a series of such experiments,
is shown. It can be observed that the current densities of
dystrophic cardiomyocytes were significantly decreased (also see
Table 1). This suggests that dystrophin-deficiency reduces the
number of functional sodium channels. Extra utrophin-deficiency,
on the other hand, did not produce a considerable additional effect
in neonatal cardiomyocytes.
Analysis of the current decay after channel activation (Figure 1C)
revealed that the kinetics of inactivation was similar in wt and mdx
cardiomyocytes, but, over a certain voltage range, significantly
slowed in mdx-utr cells. These data suggest that extra utrophin-
deficiency reduces inactivation.
Comparison of the sodium channel activation and steady-state
inactivation curves between wt and dystrophic cardiomyocytes
(Figure 1D) reveals that dystrophin-deficiency alone (mdx) does
not generate any effect. In contrast, extra utrophin-deficiency
moderately shifts both curves to the right. This is represented by a
significant shift of V0.5, the voltage at which half-maximum
activation or inactivation occurred, to more positive values in
mdx-utr cardiomyocytes (Table 1). These results suggest that extra
utrophin-deficiency affects the voltage-dependence of gating in
neonatal cardiomyocytes.
Finally, Figure 1E shows that the recovery from inactivation is
similar in wt and dystrophic neonatal cardiomyocytes.
Properties of currents through L-type calcium channels in
normal and dystrophic neonatal cardiomyocytes
Having shown that sodium channels are impaired already in
dystrophic neonatal cardiomyocytes (prior to cardiomyopathy
development), it was of interest to test if this is a special feature of
sodium channels in the dystrophic neonatal heart, or more
generally also applies to other ion channels. Therefore, we
compared the properties of calcium channels in wt and dystrophic
neonatal cardiomyocytes. Figure 2 shows that the barium current
densities were similar in wt and dystrophic cardiomyocytes (B).
Analysis of the current decay after channel activation revealed that
the kinetics of inactivation was slowed in dystrophic cells
(Figure 2C). This effect was somewhat more pronounced in
mdx-utr compared to mdx cardiomyocytes, suggesting that extra
utrophin-deficiency produces an additional effect. Because of
considerable variation in the data, however, the difference
between mdx and mdx-utr did not reach statistical significance.
In addition, to test for calcium-dependent inactivation, in several
experiments, besides barium also calcium was used as charge
carrier. Because of the comparably small calcium current
amplitudes obtained (normally ,150 pA), current decay was only
analysed at one potential (0 mV), at which the elicited current was
near maximum. The current decay kinetics (t –values derived
from single exponential decay fits) was 1561 ms (n=14) in wt,
2362 ms (n=13) in mdx, and 2362 ms (n=6) in mdx-utr.
ANOVA revealed a significant difference (p,0.01) between the
three tested groups. Tukey’s Post Hoc test revealed significant
differences both between mdx and wt (p,0.01), and between mdx-
utr and wt (p,0.05), but not between mdx and mdx-utr. Together,
these data suggest that calcium channel inactivation is significantly
reduced in dystrophic neonatal cardiomyocytes. Finally, steady-
state inactivation was similar in wt and dystrophic cells (Figure 2D).
Sodium current properties in normal and dystrophic
adult cardiomyocytes
To assess developmental changes in ion channel abnormalities
in the dystrophic heart, we studied sodium channel properties also
in cardiomyocytes derived from dystrophic adult (4–6 months old)
mice. These were then compared with the respective findings on
dystrophic neonatal cardiomyocytes. Figure 3 indicates that, as
shown above for neonatal cardiomyocytes, the sodium current
density was reduced in dystrophic compared to wt adult
cardiomyocytes (B and C). Generally, this current density
reduction was much more pronounced in dystrophic adult
compared to dystrophic neonatal cardiomyocytes (compare
Figures 1 and 3). In addition, in contrast to neonatal cells, in
adult cardiomyocytes, extra utrophin-deficiency produced an
additional effect on current density. Thus, we found a significant
current density reduction in mdx-utr compared with mdx
cardiomyocytes.
Figure 3D compares the sodium channel activation and steady-
state inactivation between wt and dystrophic adult cardiomyo-
cytes. These curves were similar in wt, mdx and mdx-utr cells.
This is in contrast to the small but significant right shifts of both
the activation and inactivation curves in neonatal mdx-utr
cardiomyocytes, when compared to the wt and mdx (Figure 1D,
Table 1).
Action potentials in normal and dystrophic adult
cardiomyocytes
To estimate the effects of the strong sodium current reduction in
dystrophic adult cardiomyocytes on the cardiac action potential
(AP), we recorded APs from adult wt, mdx and mdx-utr
Ion Channel Dysfunction in the Dystrophic Heart
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e20300Figure 1. Sodium channel properties in wt and dystrophic neonatal cardiomyocytes. A. Original current traces of a typical wt, mdx, and
mdx-utr cardiomyocyte, elicited by depolarising voltage-steps. B. Current-voltage relationships derived from a series of experiments as shown in A.
The Inset (bar graph) shows a comparison of the maximum current densities between wt and dystrophic cardiomyocytes. C. Comparison of the
current decay kinetics between wt and dystrophic cardiomyocytes at different membrane voltages. Decay half-times represent the time periods
between the current peak and the time point at which the current had decayed to 50%. * indicates that ANOVA revealed a significant difference
(p,0.05) between the respective parameters of the three tested groups. Tukey’s Post Hoc test for comparison between two groups revealed
significant differences (p,0.05) between mdx-utr and wt, and between mdx-utr and mdx. D. Voltage-dependencies of activation and steady-state
inactivation in wt and dystrophic cardiomyocytes. E. Recovery from inactivation in wt and dystrophic cardiomyocytes. Data were fit with a single
exponential function. The pulse protocols are shown as insets in the respective graphs. Data points represent means 6 SEM. Detailed statistics and
n-values are given in Table 1.
doi:10.1371/journal.pone.0020300.g001
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found a significant decrease in AP upstroke velocity and amplitude
in dystrophic cardiomyocytes (Figure 4, lower panel). A significant
additional effect of extra utrophin-deficiency, as expected from the
decreased sodium current density in mdx-utr compared to mdx
cardiomyocytes, was not observed here. Such an effect was only
existent by trend in the AP upstroke velocity. AP duration analyses
at 30% repolarisation revealed 1.660.2 ms for wt, 2.160.5 ms for
mdx, and 3.461.6 ms for mdx-utr. At 50% repolarisation, the
respective values were 3.860.6 ms for wt, 4.161.2 ms for mdx,
and 5.862.3 ms for mdx-utr. At 90% repolarisation AP durations
were 24.264.2 ms in wt, 1965.7 ms in mdx, and 25.169.9 ms in
mdx-utr. No significant differences existed between any of these
AP duration values. Finally, the resting membrane potential was
27862 mV in wt, 27663 mV in mdx, and 27662 mV in mdx-
utr.
Surface electrocardiogram (ECG) recordings on normal
and dystrophic neonatal and adult mice
Reducedsodiumcurrentsand aslowedAPupstrokeindystrophic
ventricular cardiomyocytes, as presented in this study, may affect
cardiac ventricular conduction. This was tested by comparison of
the QRS intervals derived from ECG recordings on wt and
dystrophic mice. Figure 5 shows that, in neonatal mice, the QRS
interval was very similar in wt and dystrophic animals. In adult
mice, the QRS interval was significantly prolonged in dystrophic
compared to wt animals, whereby extra utrophin-deficiency did not
produce any additional effect (Figure 5). This suggests that the
comparably moderate sodium channel impairments observed in
dystrophic neonatal cardiomyocytes do not suffice to impair
ventricular conduction. In contrast, the more severe sodium current
reduction in dystrophic adult cardiomyocytes considerably slows
ventricular conduction, independent of extra utrophin-deficiency.
Further analyses of the ECG recordings shown in Figure 5 revealed
PR interval durations of 3061 ms for wt, 2861 ms for mdx, and
2761 ms for mdx-utr in neonatal mice. ANOVA revealed a
significant difference (p,0.05) between the PR interval values of the
three tested groups. Tukey’s Post Hoc test for comparison between
two groups revealed significant differences (p,0.05) between mdx
and wt, and between mdx-utr and wt. In adult mice, the PR
intervals were 4961 ms in wt, 4361 ms in mdx, and 4362m si n
mdx-utr (p,0.01, ANNOVA). Tukey’s Post Hoc test revealed
significant differences (p,0.05) between mdx and wt, and between
mdx-utr and wt. Finally the heart rates of neonatal mice were
624615 beats per minute (bpm) in wt, 589629 bpm in mdx, and
588618 bpm in mdx-utr. In adult mice, the heart rates were
514616 bpm in wt, 566612 bpm in mdx, and 55167 bpm in
mdx-utr. Both in neonatal and adult mice, there was no significant
difference between the heart rates of the three tested groups.
Discussion
Here we report significant ion channel impairments in
dystrophic neonatal and adult cardiomyocytes. Very recently, a
study on the regulation of the Nav1.5 channel by utrophin in
dystrophin-deficient mice was published [10], in which part of our
results on adult cardiomyocytes were confirmed. In [10] adult
cardiomyocytes derived from the same mouse models (mdx and
mdx-utr), and animals of considerably younger age (8–10 weeks),
compared with our study (4–6 months), were investigated. Similar
to our results, [10] reported a significant reduction in sodium
current density in mdx cardiomyocytes, and a further reduction in
extra utrophin-deficient mdx-utr cardiomyocytes, which was
accompanied by decreased Nav1.5 protein levels in the hearts of
mdx-utr mice. In contrast to [10], we did not observe small but
significant right shifts in the sodium current activation and steady-
state inactivation curves in dystrophic adult cardiomyocytes.
Interestingly, however, we found such shifts in extra utrophin-
deficient neonatal cardiomyocytes (Figure 1D). The reason for this
discrepancy between our findings and [10] is not known. It is,
Table 1. Sodium and barium current parameters in wt and dystrophic cardiomyocytes.
Activation Inactivation
V05 k Vrev Current Density n V05 k n
Na
+ currents mV mV mV pA/pF mV mV
Neonatal wt 234.061.6 6.660.3 20.061.4 211568 (11) 27062.5 7.860.2 (8)
mdx 234.260.8 6.760.3 22.460.6 28966&( 1 5 ) 268.461.2 8.760.2& (15)
mdx-utr 229.561.21$ 6.860.2 22.460.8 2816101 (12) 263.761.7 7.960.2$ (15)
Adult wt 227.661.0 6.160.1 23.5±0.9 2201±25 (11) 256.760.9 8.460.1 (10)
mdx 227.361.1 6.260.3 24.7±0.9 2122±17&( 1 1 ) 258.261.3 8.360.3 (11)
mdx-utr 227.461.3 6.760.3 20.3±0.9$$ 269±9111$ (10) 256.760.9 8.160.2 (10)
Ba
2+ currents
Neonatal wt 6.661.5 7.560.3 60.661.3 27.161.0 (15) 222.860.6 7.361.1 (6)
mdx 5.960.9 6.860.3 59.161.3 25.961.0 (13) 219.961.5 7.660.7 (5)
mdx-utr 7.161.3 7.660.4 60.761.3 25.860.8 (14) 221.561.3 7.160.6 (6)
The given parameters were obtained by the analysing procedures described in Materials and Methods. V0.5 is the voltage at which half-maximum activation or
inactivation occurred, and k represents the slope factor. Vrev is the reversal potential, and n gives the number of experiments. Values represent means 6 SEM. Data in
italic indicate that ANOVA revealed a significant difference (p,0.05) between the respective parameters of the three different groups (wt, mdx, and mdx-utr). Data in
bold indicate that ANOVA revealed p,0.01. Statistical comparisons between two groups were made using Tukey’s Post Hoc test. Here,
&p,0.05 indicates a significant difference between mdx and wt.
1p,0.05 and
111p,0.001 indicate significant differences between mdx-utr and wt.
$p,0.05 and
$$p,0.01 indicate significant differences between mdx-utr and mdx.
doi:10.1371/journal.pone.0020300.t001
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above) contributes, and that the positive shifts of the activation and
inactivation curves disappear with older dystrophic animal age. A
further discrepancy between our study and [10] lies in the additive
affect of utrophin on the AP of mdx cardiomyocytes. Whereas [10]
described a significant reduction of the AP upstroke velocity in
mdx-utr compared with mdx cells, we did not find this significant
difference, but only a minor trend in the same direction. In
accordance with [10], on the other hand, we report similar AP
amplitudes in mdx and mdx-utr cardiomyocytes.
Ion channel dysfunction precedes cardiomyopathy
development in the dystrophic heart
Heart failure leads to electrical remodelling including impair-
ments of ion channel expression and function (reviewed in [24]).
Since cardiomyopathy development and concomitant heart failure
is also an important feature of the pathology observed in DMD
patients [2,3], as well as in DMD mouse models (e.g. [16–18]), it is
likely that ion channel impairments also evolve in the dystrophic
heart. All the studies which have previously reported aberrant
sodium channel properties in dystrophic cardiomyocytes [5,7,10]
Figure 2. Calcium channel properties in wt and dystrophic neonatal cardiomyocytes. A. Original barium current traces (five episodes
displayed) of a wt and mdx-utr cardiomyocyte, elicited by the pulse protocol on top. The prepulse was used to eliminate currents through T-type
calcium channels. B. Current-voltage relationships derived from a series of experiments on wt and dystrophic cardiomyocytes as shown in A. C.
Comparison of the current decay kinetics between wt and dystrophic cardiomyocytes at various membrane voltages. t –values were derived from
single exponential fits of the current decay after channel activation. * indicates a significant difference (ANOVA, p,0.05) between the three tested
groups. Tukey’s Post Hoc test revealed a significant difference (p,0.05) between mdx-utr and wt, but not between mdx-utr and mdx. D. Voltage-
dependency of steady-state inactivation in wt and dystrophic cardiomyocytes. For n-values see Table 1.
doi:10.1371/journal.pone.0020300.g002
Ion Channel Dysfunction in the Dystrophic Heart
PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20300were performed on adult mice. Thus, it is unclear, if the described
sodium channel defects are primary effects of dystrophic gene
mutations, or secondary effects resulting from the developing
cardiac pathology. Importantly, here we show that significant
sodium channel impairments are already present in dystrophic
cardiomyocytes derived from neonatal mice. Since it is well
established that cardiac abnormalities are absent in the used
dystrophy mouse models even in young adult animals (e.g.
[16,18,21–23]), these sodium channel defects in dystrophic
neonatal cardiomyocytes can be considered primary effects of
the dystrophic gene mutations, which precede cardiomyopathy
development. Our additional finding of a significantly reduced
calcium channel inactivation in dystrophic neonatal cardiomyo-
cytes suggests that this is not a special feature of sodium channels
alone, but more generally applies to other voltage-gated ion
channels as well.
Recently, transgenic mice with reduced expression of Nav1.5
channels in the heart were shown to develop a dilated
cardiomyopathy [13]. This work, together with a study on
heterozygous SCN5A-knockout mice [25], and reports associating
mutations in the SCN5A gene with cardiomyopathy (e.g. [14,15]),
suggests that aberrant Nav1.5 channel expression and function are
underlying mechanisms for cardiomyopathy. Since we found both
reduced sodium currents (mdx, mdx-utr) and impaired sodium
channel gating (only mdx-utr) in dystrophic neonatal cardiomy-
ocytes, this may also be true for dystrophic cardiomyopathy. In
this context it is tempting to speculate that the additional sodium
channel gating impairments, only present in neonatal mdx-utr- but
not in mdx- cardiomyocytes, may contribute to the more severe
cardiomyopathy development observed in mdx-utr compared with
mdx mice [16,17,20]. Indeed, these gating impairments may even
represent the crucial cardiomyopathy worsening factor, when
considering that the sodium current densities in neonatal mdx and
mdx-utr cardiomyocytes were similar.
Besides reduced sodium currents in cardiomyocytes [13], also
increased calcium currents may initiate cardiomyopathy develop-
ment. Thus, transgenic mice with an increased number of L-type
calcium channels in the heart developed a severe cardiomyopathy
[26]. Here we report considerably reduced calcium channel
inactivation in dystrophic neonatal cardiomyocytes, which should
enhance calcium influx through these channels. This may lead to
increases in intracellular calcium, and in line with [26], possibly
also contribute to cardiomyopathy development.
Finally, our finding of a more severe sodium current reduction
in dystrophic adult compared to dystrophic neonatal cardiomyo-
cytes may suggest that the developing pathology in the dystrophic
Figure 3. Sodium channel properties in wt and dystrophic adult cardiomyocytes. A. Original current traces of a typical wt, mdx, and mdx-
utr cardiomyocyte, elicited by the pulse protocol in B. B. Current-voltage relationships derived from a series of experiments as shown in A. C.
Maximum current densities in wt and dystrophic cardiomyocytes. *** indicates that ANOVA revealed a significant difference (p,0.001) between the
three tested groups. D. Comparison of the voltage-dependencies of activation and steady-state inactivation between wt and dystrophic
cardiomyocytes. For detailed statistics and n-values see Table 1.
doi:10.1371/journal.pone.0020300.g003
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properties. If so, the stronger sodium current reduction we found
in adult mdx-utr, compared with adult mdx cardiomyocytes, may
be related to the more severe cardiomyopathy observed in mdx-utr
mice. Thus, whereas in mdx mice a cardiomyopathy evolves
comparably slow (e.g. [18]), in the mdx-utr mouse model, cardiac
abnormalities including cardiomyocyte necrosis, inflammation,
fibrosis and contractile dysfunction are known to be strongly
present in the animal age range used in this study (4–6 months)
[16,17,20].
Extra utrophin-deficiency worsens electrophysiological
abnormalities in mdx cardiomyocytes
We show here that extra utrophin-deficiency generates
significant sodium current abnormalities in addition to those
produced by dystrophin-deficiency only. Similar results were
recently reported by [10]. Whereas [10] studied cardiomyocytes
from young adult (8–10 weeks) dystrophic (mdx and mdx-utr) mice
only, we have investigated cardiomyocytes from neonatal and
considerably older adult (4–6 months) dystrophic mice, thereby
providing new information on the development and progression of
the sodium channel impairments in extra utrophin-deficient
dystrophic cardiomyocytes. Our findings are in accordance with
a strong regulatory effect of utrophin on cardiac Nav1.5 channels
in dystrophin-deficient mdx mice. This may occur by indirect
interaction of utrophin with Nav1.5 via syntrophins [10].
A recent study [27] suggests that, besides improving Nav1.5
channel impairments in the case of dystrophin-deficiency,
utrophin may also rescue other impaired electrophysiological
properties. Thus, these authors reported a more severe impair-
ment in skeletal muscle excitation-contraction coupling in mdx-utr
compared to mdx mice. Since utrophin interacts with several
protein members of the DAPC [28,29], and DAPC members
interact with ion channels (e.g. [7,30]), the described rescue effects
by utrophin may be achieved by restoring the integrity of the
disrupted DAPC when dystrophin is absent.
Sodium channel impairments in adult cardiomyocytes
affect conduction in the dystrophic heart
Since the sodium channel impairments in dystrophic neonatal
and adult ventricular cardiomyocytes are considerably different,
namely more severe in adult cells, it was of interest to test their
functional relevance, by comparing their impacts on cardiac
ventricular conduction. The results suggest that the sodium
channel impairments in dystrophic neonatal cardiomyocytes do
not suffice to delay ventricular conduction. This is suggested by
similar QRS intervals in ECG recordings on wt and dystrophic
neonatal mice. Concomitant with a pronounced retardation of the
AP upstroke in dystrophic adult cardiomyocytes, ECG recordings
on adult mice, in contrast to those on neonatal ones, revealed
considerably prolonged QRS intervals in dystrophic compared to
wt animals. In line with previous mdx mouse studies [5,7,31], this
suggests that ventricular conduction is considerably slowed in
dystrophic adult animals, most probably due to the strongly
reduced sodium channel availability. An additional QRS interval
prolongation by extra utrophin-deficiency in adult animals, as
would be expected from the pronounced sodium current reduction
especially in mdx-utr cardiomyocytes, was not observed here. In
contrast, QRS was very similar in adult mdx and mdx-utr mice,
and thus, independent of extra utrophin-deficiency. The reason for
this surprising finding is not known. It may be explained by
alterations in other factors than sodium channels, which also
modulate cardiac conduction, and counteract the effects generated
by reduced sodium currents.
Figure 4. Action potential properties in wt and dystrophic adult cardiomyocytes. Typical AP of a wt cardiomyocyte (top left) elicited by a
4-ms current injection at 125% threshold. On the top right, the upstrokes of typical APs recorded from wt and dystrophic cardiomyocytes are
overlayed on an expanded time scale. In the lower panel, maximum upstroke velocity (max. dV/dt), and the maximum depolarisation value reached
by the AP (abs. amplitude) are plotted against the membrane potential. * and ** indicate significant differences (ANOVA; p,0.05 and ,0.01; n-values:
5–8) between the three tested groups, respectively. Tukey’s Post Hoc test revealed no significant differences between mdx-utr and mdx.
doi:10.1371/journal.pone.0020300.g004
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dystrophic and wt mice, the PR interval of the ECG (reflecting
AV nodal conduction) was significantly shortened already in
dystrophic neonatal animals. This may be related to enhanced
calcium currents due to reduced calcium channel inactivation in
dystrophic neonatal cardiomyocytes. This hypothesis, however,
requires that calcium channel inactivation is similarly impaired in
AV nodal cardiomyocytes as in ventricular cardiomyocytes, which
was not verified in this study. The PR interval shortening, which
was independent of extra utrophin-deficiency, was more pro-
nounced in dystrophic adult mice, and matches with previous
studies (e.g. [31,32]).
Clinical implications
If the dystrophin/utrophin double mutant mouse is indeed a
suitable model for DMD with representative cardiac pathology
(probably superior to the mdx mouse), as suggested by several
groups (e.g. [16,19,20]), our finding of a more severe cardiac
sodium channel dysfunction in this mouse model has an important
implication: sodium channel impairments may be considered a
major cause of the cardiac conduction defects observed in DMD
patients [11,12], probably as yet underestimated when using the
common mdx mouse as model system. This critical loss of sodium
current in dystrophic cardiomyocytes may be further corroborated
by increasing myocardial fibrosis during disease progression. Thus,
paracrine factors released from cardiac fibroblasts slow impulse
conduction and reduce Nav1.5 channel expression in cardiomy-
ocytes [33]. Consequently, drugs that directly enhance cardiac
sodium currents, or strategies indirectly enhancing sodium
currents, e.g. by overexpression of endogenous utrophin, may be
useful to restore normal conduction and prevent life-threatening
arrhythmias in DMD patients.
A second important implication of our study emerges from the
finding that ion channel impairments precede cardiomyopathy
development in the dystrophic heart. Both reduced sodium
currents [13] and increased calcium currents [26] in cardiomy-
ocytes are considered potential underlying mechanisms for
cardiomyopathy development. Since the ion channel impairments
we found in dystrophic neonatal cardiomyocytes prior to cardiac
pathology development, entail exactly these effects on the named
currents, we speculate that they contribute to initiate cardiomy-
opathy development in the dystrophic heart. If so, drugs that
enhance sodium currents and/or decrease calcium currents can be
considered strategies to prevent dystrophic cardiomyopathy
development.
Materials and Methods
The study coincides with the rules of the University Animal
Welfare Committee, and conforms with the European Commis-
sion Directive 86/609/EEC. For animal research, approval was
granted by the Austrian Ministry for Science and Research
(BMWF-66.009/0211-II/10b/2009).
Mouse models
Normal wild type (wt) C57/BL6 mice, dystrophin-deficient mdx
[9] and dystrophin/utrophin-deficient double mutant mdx-utr
Figure 5. Surface ECG recordings on wt and dystrophic neonatal and adult mice. (Top) Typical original ECG signals (lead 1) from neonatal
and adult wt mice, and the corresponding averages over 100 beats (insets). (Bottom right) Overlay of representative QRS-complexes (lead 2) in adult
wt and mdx mice. In the graph, the QRS intervals of neonatal and adult ECGs are compared between wt and dystrophic mice. *** significant
difference (ANOVA, p,0.001, n-values: 6–15) between the three tested groups. No significant differences exist between mdx-utr and mdx.
doi:10.1371/journal.pone.0020300.g005
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than 10 generations, were used for the study. Throughout the text,
the dystrophin2/2 status (utrophin+/+) is termed ‘‘mdx’’.
Double mutant (dystrophin2/2 and utrophin2/2) mice are
referred to as ‘‘mdx-utr’’. The mice were genotyped by standard
PCR-assays. For comparisons between mdx and mdx-utr,
littermates were used in all electrophysiological experiments.
Preparation of neonatal ventricular cardiomyocytes
Cardiomyocytes were isolated from the ventricles of neonatal
(1–2 days) mouse hearts. After decapitation of the mice, hearts
were rapidly excised, and the ventricular tissue was mechanically
dissociated, followed by proteolytic digestion. The isolated
cardiomyocytes were grown on Matrigel-coated (Becton Dick-
inson, Schwechat, Austria) culture dishes. A detailed description of
the procedures for the isolation and culture of neonatal
cardiomyocytes is given in our earlier work [34].
Isolation of adult ventricular cardiomyocytes
Ventricular cardiomyocytes were isolated from female mice, 4–
6 months of age, by using a Langendorff setup, which was custom-
built in our lab. Animals were killed by cervical dislocation, and
4 ml ice-cold Ca
2+-free solution (see below) was injected in the
ventricles to stop contractions and rinse free of blood. Hearts were
rapidly excised and a cannula was inserted into the aorta for
retrograde perfusion with Ca
2+-free solution (in mM: 134 NaCl,
11 glucose, 4 KCl, 1.2 MgSO4, 1.2 Na2HPO4, 10 Hepes, pH
adjusted to 7.35 with NaOH) containing 0.17 mg/ml Liberase
TH
(Roche) at 37uC for 18 min. To increase the viability of the
cardiomyocytes, 10 mM 2, 3-butanedione monoxime (BDM,
Sigma) was also added. The ventricles were then cut into pieces,
incubated on a shaker at 37uC, and calcium concentration was
increased to 200 mM over one hour in five steps. Pieces of digested
ventricular tissue were then triturated to liberate cardiomyocytes.
After centrifugation (3 min, 500 rpm), cells were resuspended in
Minimum Essential Medium (MEM) alpha (Gibco), containing
ITS media supplement (Sigma) diluted 1:100 (final concentration
of 10 mg/ml insulin, 5.5 mg/ml transferrin, 5 ng/ml selenite),
4 mM L-glutamine, 50 u/ml penicillin, 50 mg/ml streptomycin
and 25 mM blebbistatin (Sigma). Cells were plated on Matrigel
(Becton Dickinson)-coated culture dishes.
Electrophysiological studies using the whole cell patch
clamp technique
A detailed description of the electrophysiological recordings is
given in our earlier work [34]. Ionic currents were recorded from
neonatal cardiomyocytes up to 24 hours, and from adult
cardiomyocytes up to 8 hours after preparation at room
temperature (2261.5uC), using an Axoclamp 200B patch clamp
amplifier (Axon Instruments, Union City, CA). Pipettes were
formed from aluminosilicate glass (AF150-100-10; Science Prod-
ucts, Hofheim, Germany) with a P-97 horizontal puller (Sutter
Instruments, Novato, CA), and had resistances between 0.8 and
2M V when filled with the respective pipette solutions (see below).
Data acquisition was performed with pClamp 6.0 software (Axon
Instruments) through a 12-bit A-D/D-A interface (Digidata 1200;
Axon Instruments). Data were low-pass filtered with 1–10 kHz
(23 dB) and digitized at 10–100 kHz. Data analysis was
performed using Clampfit 10.2 (Axon Instruments) and GraphPad
Prism 5.01 (San Diego, USA) software.
Sodium currents. Current-voltage (IV) relationships were fit
with the function: I=Gmax*(V2Vrev)/(1+exp((V0.52V)/K)) where
I is the current, Gmax is the maximum conductance, V is the
membrane potential, Vrev is the reversal potential, V0.5 is the
voltage at which half-maximum activation occurred, and K is the
slope factor. Decay half-time, a measure of fast inactivation
kinetics, was obtained by analysing the time period between the
current peak and the time point at which the current had decayed
to 50%. Steady-state fast inactivation data were fit with the
Boltzmann function: I/Imax=1/(1+exp((V2V0.5)/K)) where I/
Imax is the normalized current, V is the membrane potential, V0.5
is the voltage at which half-maximum inactivation occurred, and
K is the slope factor. Recordings were made in a bath solution that
consisted of 15 mM NaCl, 125 mM N-methyl-D-glucamine
(NMDG), 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2,1 0m M
HEPES, pH=7.4 adjusted with HCl. The pipette solution
contained 105 mM CsF, 10 mM NaCl, 10 mM EGTA, 10 mM
HEPES, pH=7.3 adjusted with CsOH. Chemicals were
purchased from Sigma. Rapid solution changes were performed
by a DAD-8-VC superfusion system (ALA Scientific Instruments,
Westbury, NY).
Barium currents. The external solution contained 10 mM
BaCl2, 145 mM TEA-Cl, 10 mM Hepes, pH=7.4 adjusted with
TEA-OH. The internal solution contained 145 mM Cs-aspartate,
2 mM MgCl2, 10 mM Hepes, 0.1 mM Cs-EGTA, 2 mM Mg-
ATP, pH=7.4 adjusted with CsOH. The kinetics of barium
current inactivation was analysed by fitting the current decay after
channel activation with a single exponential function. In
experiments where calcium was used as charge carrier, the
external solution contained 10 mM CaCl2 instead of 10 mM
BaCl2.
Action potential recordings. APs were recorded from adult
cardiomyocytes derived from 4–6 months old female mice in the
current-clamp mode of the whole cell patch clamp technique. APs
were elicited at 1 Hz from defined membrane potentials (fixed by
continuous current injection) by rectangular current pulses of 4 ms
duration at 125% threshold level. The cells were bathed in
140 mM NaCl, 4 mM KCl, 2 mM CaCl2, 2 mM MgCl2,5m M
Hepes, 5 mM Glucose, pH=7.4 adjusted with NaOH. The
pipette solution contained 10 mM NaCl, 140 mM KCl, 2 mM
EGTA, 1 mM MgCl2, 0.1 mM Na-GTP, 5 mM Mg-ATP,
10 mM Hepes, pH=7.2 adjusted with KOH.
Surface electrocardiogram recordings
Standard 6-lead surface electrocardiograms (ECGs) were
recorded from conscious neonatal (8–14 days) and anaesthetized
adult (4–6 months) mice. ECG recordings from neonatal mice
were performed as in [35]. In brief, a custom-built setup restrained
neonatal mice in movement. Four Ag/AgCl-electrode footpads
were used to record ECGs. The pads were wetted with ECG
electrode gel, and each foot was placed such that it made contact
with a separate electrode. Adult mice were anaesthetized with
350 mg/kg chloral hydrate (single injection, ip), and depth of
anaesthesia was monitored (minimal response to hind-foot pinch).
Small-needle ECG leads were placed subcutaneously on all 4
extremities. Body temperature was maintained at 37uC using a
heating pad and lamp. Signals were amplified (Gould model 11
G412301; Gould Inc., Cleveland, Ohio, USA), high- and low-pass
filtered with 3 dB cut-off frequencies of 0.3 and 1 kHz,
respectively, digitized at 5 kHz, and stored for offline analysis.
To reduce noise levels, ECG signals were averaged over 100 beats
prior to evaluation. QRS interval values were determined by
calculating the mean of all 6 standard leads. The duration of the
QRS interval was measured from the sharp onset to the offset of
depolarization as in [36]. The PR interval was measured from the
beginning of the P wave to the beginning of the QRS complex (see
insets in Figure 5).
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were made using one way ANOVA (for independent samples) and
Tukey’s Post Hoc test. A p-value,0.05 was considered significant.
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